GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aurora Cannabis Inc (FRA:21P) » Definitions » Debt-to-EBITDA

Aurora Cannabis (FRA:21P) Debt-to-EBITDA : 3.09 (As of Sep. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Aurora Cannabis Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Aurora Cannabis's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was €39.1 Mil. Aurora Cannabis's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was €28.1 Mil. Aurora Cannabis's annualized EBITDA for the quarter that ended in Sep. 2024 was €21.7 Mil. Aurora Cannabis's annualized Debt-to-EBITDA for the quarter that ended in Sep. 2024 was 3.09.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Aurora Cannabis's Debt-to-EBITDA or its related term are showing as below:

FRA:21P' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -8.49   Med: -0.96   Max: 24.17
Current: 24.17

During the past 13 years, the highest Debt-to-EBITDA Ratio of Aurora Cannabis was 24.17. The lowest was -8.49. And the median was -0.96.

FRA:21P's Debt-to-EBITDA is ranked worse than
97.41% of 656 companies
in the Drug Manufacturers industry
Industry Median: 1.67 vs FRA:21P: 24.17

Aurora Cannabis Debt-to-EBITDA Historical Data

The historical data trend for Aurora Cannabis's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aurora Cannabis Debt-to-EBITDA Chart

Aurora Cannabis Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Mar24
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3.18 -0.17 -0.75 -0.17 -8.49

Aurora Cannabis Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.60 -1.84 -5.15 1.68 3.09

Competitive Comparison of Aurora Cannabis's Debt-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Aurora Cannabis's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aurora Cannabis's Debt-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Aurora Cannabis's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Aurora Cannabis's Debt-to-EBITDA falls into.



Aurora Cannabis Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Aurora Cannabis's Debt-to-EBITDA for the fiscal year that ended in Mar. 2024 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(38.889 + 32.335) / -8.388
=-8.49

Aurora Cannabis's annualized Debt-to-EBITDA for the quarter that ended in Sep. 2024 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(39.078 + 28.081) / 21.72
=3.09

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Sep. 2024) EBITDA data.


Aurora Cannabis  (FRA:21P) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Aurora Cannabis Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Aurora Cannabis's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Aurora Cannabis Business Description

Traded in Other Exchanges
Address
2207 90B Street SW, Edmonton, AB, CAN, T6X 1V8
Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements.

Aurora Cannabis Headlines

No Headlines